Neuronetics, Inc (STIM)

Etorro trading 970x250
Neuronetics, Inc (STIM) Logo

About Neuronetics, Inc

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2003 and is headquartered in Malvern, Pennsylvania. Address: 3222 Phoenixville Pike, Malvern, PA, United States, 19355

Neuronetics, Inc News and around…

Latest news about Neuronetics, Inc (STIM) common stock and company :

5 Penny Stocks Insiders Are Buying
26 Nov, 2021 FinancialContent

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Neuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov, 2021 Yahoo! Finance

MALVERN, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer, will participate in a fireside chat at the Piper Sandler 33rd Annual Virt

How The Pieces Add Up: OMFS Targets $52
18 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Russell 2000—Dynamic Multifactor ETF (OMFS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $51.52 per unit.

Neuronetics, Inc. (STIM) Q3 2021 Earnings Call Transcript
09 Nov, 2021 FinancialContent

STIM earnings call for the period ending September 30, 2021.

Neuronetics Reports Third Quarter 2021 Financial and Operating Results
09 Nov, 2021 Yahoo! Finance

MALVERN, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced its financial and operating results for the third quarter of 2021. Third Quarter 2021 Highlights As previously announced, third quarter 2021 revenue of $13.8 million, an increase of 11% over third quarter 2020 Enter

Neuronetics and River Region Psychiatry Announce Exclusive Partnership
08 Nov, 2021 Yahoo! Finance

Partnership Will Bring Non-drug NeuroStar® Advanced Therapy For Mental Health To Thousands of Patients Across the Southeast MALVERN, Pa., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, and River Region Psychiatry Associates (RRPA), a leading provider of mental health services in Alabama, Ken

Artificial Intelligence Could Be About To Replace Your Doctor
02 Nov, 2021 FinancialContent
Anika Appoints Sheryl Conley to Board of Directors
01 Nov, 2021 Yahoo! Finance

Appointment brings experienced orthopedic industry commercial leader to Anika’s BoardBEDFORD, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that its Board of Directors has appointed Sheryl Conley as independent director, effective October 28, 2021. Sheryl Conley joins the Anika Board of Directors with over 35 years of orthopedic and healthcare industry experience, mo

Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
26 Oct, 2021 Yahoo! Finance

The Company honors one of its largest providers for helping patients overcome depression with NeuroStar Advanced Therapy for Mental HealthMALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced a leading provider, Success TMS, has reached an impressive milestone delivering ov

Neuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call
26 Oct, 2021 Yahoo! Finance

MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it plans to release third quarter financial and operating results prior to market open on Tuesday, November 9, 2021. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the s

Analysts Estimate Neuronetics (STIM) to Report a Decline in Earnings: What to Look Out for
25 Oct, 2021 Yahoo! Finance

Neuronetics (STIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

This Isn’t Sci-Fi: How AI Is About To Disrupt This $11 Trillion Industry
21 Oct, 2021 Yahoo! Finance

Artificial intelligence is here, and it’s disrupting entire industries. Now, it’s coming to the healthcare sector, and it could change everything we know about medicine

CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021
20 Oct, 2021 Yahoo! Finance

MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, October 12th from Neuronetics, Inc. (NASDAQ: STIM), please note that the Safe Harbor Statement was inadvertently omitted. No changes were made to the content of the press release and the Safe Harbor Statement has been added, the corrected release follows: Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that

Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
19 Oct, 2021 Yahoo! Finance

System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today the release of the latest evolution of their NeuroStar® Advanced Therapy system with upgraded equipment and features. NeuroStar® Advanced

A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector
18 Oct, 2021 FinancialContent
First Week of December 17th Options Trading For Neuronetics (STIM)
15 Oct, 2021 FinancialContent

Investors in Neuronetics Inc (STIM) saw new options begin trading this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the STIM options chain for the new December 17th contracts and identified the following call contract of particular interest.

The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors
14 Oct, 2021 FinancialContent

The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors

Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?
14 Oct, 2021 Yahoo! Finance

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

50 Biggest Movers From Yesterday
14 Oct, 2021 FinancialContent

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated ...

Mid-Afternoon Market Update: Nasdaq Jumps 100 Points; Jasper Therapeutics Shares Spike Higher
13 Oct, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded up 0.06% to 34,398.86 while the NASDAQ rose 0.70% to 14,566.72. The S&P also ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
13 Oct, 2021 FinancialContent

Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The ...

Mid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge
13 Oct, 2021 FinancialContent

Midway through trading Wednesday, the Dow traded down 0.43% to 34,229.72 while the NASDAQ rose 0.40% to 14,524.02. The S&P also ...

40 Stocks Moving In Wednesday's Mid-Day Session
13 Oct, 2021 FinancialContent

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock ...

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021
13 Oct, 2021 FinancialContent

Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ:COLB) from Neutral to Buy. In the second ...

Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings
13 Oct, 2021 FinancialContent

Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P ...

Neuronetics Cuts Q3 Revenue Guidance; Shares Tank 27% Pre-Market
13 Oct, 2021 Yahoo! Finance

Commercial stage medical technology company Neuronetics Inc. (STIM) expects to report total revenue of $13.8 million in the third quarter of 2021, lower than the previously issued guidance of $15 million to $16 million and the Street’s estimate of $16.51 million. Following the announcement, shares of the company declined nearly 27%, at the time of writing, in pre-market trade on Wednesday. Based out of Pennsylvania, Neuronetics is engaged in the design, development and sale of products to treat

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
13 Oct, 2021 FinancialContent

Gainers Revance Therapeutics (NASDAQ:RVNC) stock moved upwards by 17.79% to $24.09 during Wednesday's pre-market ...

The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
13 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
13 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're at the halfway point of the trading week and that has us checking in on the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

20 Stocks Moving in Wednesday's Pre-Market Session
13 Oct, 2021 FinancialContent

Gainers Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday. Jasper Therapeutics, ...

Neuronetics, Inc (STIM) is a NASDAQ Common Stock listed in , ,

970x250